This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women
All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.
Study Type
OBSERVATIONAL
Enrollment
129
evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation
Clinique Pasteur
Brest, France
Medicentre- Clinique du Val d'Ouest
Écully, France
SELARL Gynecologia
Grenoble, France
Hôpital Saint Joseph
Marseille, France
Evaluation of professional clinical practice for ovarian stimulation care
Time frame: Until 12 months followin ovarian stimulation
Arterial and/or venous thrombosis
Time frame: until 12 months following ovarian stimulation
Risk factors for thrombosis
Time frame: until 12 months following ovarian stimulation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU de Nice - Hôpital de l'Archet
Nice, France
AP-HP - Hôpital Bichat
Paris, France
Clinique Multualiste La sagesse
Rennes, France
Clinique Mathilde
Rouen, France
CHU de Strasbourg - CMCO
Schiltigheine, France